Yamamoto Takashi, Sakamoto Naoaki, Sakuma Tetsushi
Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University.
Uirusu. 2014;64(1):75-82. doi: 10.2222/jsv.64.75.
Genome editing is a cutting-edge technology that enables to modify the target gene using programmable site-specific nucleases, such as TALENs and CRISPR/Cas9. Currently, cell and animal models of human diseases have been competitively created throughout the world, because genome editing technology paved the way for genetic modifications even in cells and organisms that had been difficult to manipulate the genome. In this review, we introduce the basic principles and current situations of genome editing with programmable nucleases.
基因组编辑是一项前沿技术,它能够利用可编程的位点特异性核酸酶(如转录激活因子样效应物核酸酶(TALENs)和规律成簇间隔短回文重复序列/CRISPR相关蛋白9(CRISPR/Cas9))来修饰目标基因。目前,全球各地都在竞相创建人类疾病的细胞和动物模型,因为基因组编辑技术为在那些曾经难以操纵基因组的细胞和生物体中进行基因改造铺平了道路。在这篇综述中,我们介绍了使用可编程核酸酶进行基因组编辑的基本原理和现状。